{"reformulated1": "How has recombinant antibody technology enabled the identification and development of novel vaccine antigens through approaches like reverse vaccinology 2.0?", "reformulated2": "What are the latest production platforms and engineering strategies for improving the efficacy and scalability of recombinant antibody-based immunotherapies, particularly in cancer treatment?", "reformulated3": "What are the advantages and clinical potentials of nanobody-based constructs compared to conventional monoclonal antibodies in therapeutic and vaccine applications?"}
